Health Care & Life Sciences » Pharmaceuticals | Proteostasis Therapeutics Inc.

Proteostasis Therapeutics Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
1,141.00
5,150.00
4,312.00
8,384.00
5,341.00
2,840
SG&A Expense
16,115.00
20,406.00
28,574.00
45,533.00
65,079.00
64,244
EBIT
15,582.00
15,683.00
24,534.00
37,455.00
59,973.00
63,182
Unusual Expense
-
76.00
63.00
7.00
66.00
22
Non Operating Income/Expense
139.00
185.00
156.00
16.00
166.00
456
Interest Expense
-
199.00
599.00
-
-
-
Pretax Income
15,720.00
15,772.00
25,040.00
37,232.00
59,432.00
61,832
Consolidated Net Income
15,720.00
15,772.00
25,040.00
37,232.00
59,432.00
61,832
Net Income
15,720.00
15,772.00
25,040.00
37,232.00
59,432.00
61,832
Net Income After Extraordinaries
15,720.00
15,772.00
25,040.00
37,232.00
59,432.00
61,832
Net Income Available to Common
22,607.00
29,646.00
23,309.00
38,610.00
59,432.00
61,832
EPS (Basic)
0.91
1.19
0.94
2.06
2.34
1.61
Basic Shares Outstanding
24,889.50
24,889.50
24,889.50
18,759.40
25,407.90
38,495.10
EPS (Diluted)
0.91
1.19
0.94
2.06
2.34
1.61
Diluted Shares Outstanding
24,889.50
24,889.50
24,889.50
18,759.40
25,407.90
38,495.10
EBITDA
14,974.00
15,256.00
24,262.00
37,149.00
59,738.00
61,404
Non-Operating Interest Income
1.00
1.00
-
246.00
641.00
872
Preferred Dividends
6,887.00
13,874.00
1,731.00
1,378.00
-
-

About Proteostasis Therapeutics

View Profile
Address
80 Guest Street
Boston Massachusetts 02135
United States
Employees -
Website http://www.proteostasis.com
Updated 07/08/2019
Proteostasis Therapeutics, Inc. engages in the research, development, and market of pharmaceutical products. Its medicines intend to treat cystic fibrosis, protein conformational and neurodegenerative diseases. The company was founded by William Balch, Jeffery W.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.